172 related articles for article (PubMed ID: 26320545)
1. Pharmacological evidence for the mediation of the panicolytic effect of fluoxetine by dorsal periaqueductal gray matter μ-opioid receptors.
Roncon CM; Almada RC; Maraschin JC; Audi EA; Zangrossi H; Graeff FG; Coimbra NC
Neuropharmacology; 2015 Dec; 99():620-6. PubMed ID: 26320545
[TBL] [Abstract][Full Text] [Related]
2. Panicolytic-like action of bradykinin in the dorsal periaqueductal gray through μ-opioid and B2-kinin receptors.
Sestile CC; Maraschin JC; Gama VS; Zangrossi H; Graeff FG; Audi EA
Neuropharmacology; 2017 Sep; 123():80-87. PubMed ID: 28554847
[TBL] [Abstract][Full Text] [Related]
3. Participation of dorsal periaqueductal gray 5-HT1A receptors in the panicolytic-like effect of the κ-opioid receptor antagonist Nor-BNI.
Maraschin JC; Almeida CB; Rangel MP; Roncon CM; Sestile CC; Zangrossi H; Graeff FG; Audi EA
Behav Brain Res; 2017 Jun; 327():75-82. PubMed ID: 28347824
[TBL] [Abstract][Full Text] [Related]
4. Interaction between μ-opioid and 5-HT1A receptors in the regulation of panic-related defensive responses in the rat dorsal periaqueductal grey.
Rangel MP; Zangrossi H; Roncon CM; Graeff FG; Audi EA
J Psychopharmacol; 2014 Dec; 28(12):1155-60. PubMed ID: 25315826
[TBL] [Abstract][Full Text] [Related]
5. μ-Opioid and 5-HT1A receptors in the dorsomedial hypothalamus interact for the regulation of panic-related defensive responses.
Roncon CM; Yamashita PSM; Frias AT; Audi EA; Graeff FG; Coimbra NC; Zangrossi H
J Psychopharmacol; 2017 Jun; 31(6):715-721. PubMed ID: 28583050
[TBL] [Abstract][Full Text] [Related]
6. Opiorphin causes a panicolytic-like effect in rat panic models mediated by μ-opioid receptors in the dorsal periaqueductal gray.
Maraschin JC; Rangel MP; Bonfim AJ; Kitayama M; Graeff FG; Zangrossi H; Audi EA
Neuropharmacology; 2016 Feb; 101():264-70. PubMed ID: 26363194
[TBL] [Abstract][Full Text] [Related]
7. Cooperative regulation of anxiety and panic-related defensive behaviors in the rat periaqueductal grey matter by 5-HT1A and μ-receptors.
Roncon CM; Biesdorf C; Coimbra NC; Audi EA; Zangrossi H; Graeff FG
J Psychopharmacol; 2013 Dec; 27(12):1141-8. PubMed ID: 23598399
[TBL] [Abstract][Full Text] [Related]
8. Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception.
Godoi MM; Junior HZ; da Cunha JM; Zanoveli JM
Pharmacol Biochem Behav; 2020 Jul; 194():172938. PubMed ID: 32376258
[TBL] [Abstract][Full Text] [Related]
9. B2-kinin receptors in the dorsal periaqueductal gray are implicated in the panicolytic-like effect of opiorphin.
Sestile CC; Maraschin JC; Rangel MP; Santana RG; Zangrossi H; Graeff FG; Audi EA
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):493-498. PubMed ID: 28797641
[TBL] [Abstract][Full Text] [Related]
10. Panicolytic-like effect of tramadol is mediated by opioid receptors in the dorsal periaqueductal grey.
Fiaes GCS; Roncon CM; Sestile CC; Maraschin JC; Souza RLS; Porcu M; Audi EA
Behav Brain Res; 2017 May; 326():52-58. PubMed ID: 28245977
[TBL] [Abstract][Full Text] [Related]
11. Facilitation of 5-HT1A-mediated neurotransmission in dorsal periaqueductal grey matter accounts for the panicolytic-like effect of chronic fluoxetine.
Zanoveli JM; Pobbe RL; de Bortoli VC; Carvalho MC; Brandão ML; Zangrossi H
Int J Neuropsychopharmacol; 2010 Sep; 13(8):1079-88. PubMed ID: 19941697
[TBL] [Abstract][Full Text] [Related]
12. The panicolytic-like effect of fluoxetine in the elevated T-maze is mediated by serotonin-induced activation of endogenous opioids in the dorsal periaqueductal grey.
Roncon CM; Biesdorf C; Santana RG; Zangrossi H; Graeff FG; Audi EA
J Psychopharmacol; 2012 Apr; 26(4):525-31. PubMed ID: 22279131
[TBL] [Abstract][Full Text] [Related]
13. The unconditioned fear produced by morphine withdrawal is regulated by mu- and kappa-opioid receptors in the midbrain tectum.
De Ross J; Avila MA; Ruggiero RN; Nobre MJ; Brandão ML; Castilho VM
Behav Brain Res; 2009 Dec; 204(1):140-6. PubMed ID: 19520121
[TBL] [Abstract][Full Text] [Related]
14. Involvement of 5-HT1A and 5-HT2 receptors of the dorsal periaqueductal gray in the regulation of the defensive behaviors generated by the elevated T-maze.
de Paula Soares V; Zangrossi H
Brain Res Bull; 2004 Aug; 64(2):181-8. PubMed ID: 15342106
[TBL] [Abstract][Full Text] [Related]
15. BDNF-TRKB signaling system of the dorsal periaqueductal gray matter is implicated in the panicolytic-like effect of antidepressant drugs.
Casarotto PC; Santos PC; Lucas GA; Biojone C; Pobbe RL; Vilela-Costa HH; Joca SR; Guimarães FS; Zangrossi H
Eur Neuropsychopharmacol; 2015 Jun; 25(6):913-22. PubMed ID: 25840741
[TBL] [Abstract][Full Text] [Related]
16. µ- and κ-Opioid receptor activation in the dorsal periaqueductal grey matter differentially modulates panic-like behaviours induced by electrical and chemical stimulation of the inferior colliculus.
Twardowschy A; Coimbra NC
Brain Res; 2015 Feb; 1597():168-79. PubMed ID: 25485771
[TBL] [Abstract][Full Text] [Related]
17. Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors.
Soares Vde P; Campos AC; Bortoli VC; Zangrossi H; Guimarães FS; Zuardi AW
Behav Brain Res; 2010 Dec; 213(2):225-9. PubMed ID: 20457188
[TBL] [Abstract][Full Text] [Related]
18. Enhanced reactivity of 5-HT1A receptors in the rat dorsal periaqueductal gray matter after chronic treatment with fluoxetine and sertraline: evidence from the elevated T-maze.
Zanoveli JM; Nogueira RL; Zangrossi H
Neuropharmacology; 2007 Mar; 52(4):1188-95. PubMed ID: 17313964
[TBL] [Abstract][Full Text] [Related]
19. 5-HT1A and 5-HT2A receptor control of a panic-like defensive response in the rat dorsomedial hypothalamic nucleus.
de Bortoli VC; Yamashita PS; Zangrossi H
J Psychopharmacol; 2013 Dec; 27(12):1116-23. PubMed ID: 23787365
[TBL] [Abstract][Full Text] [Related]
20. Chronic imipramine treatment sensitizes 5-HT1A and 5-HT 2 A receptors in the dorsal periaqueductal gray matter: evidence from the elevated T-maze test of anxiety.
Zanoveli JM; Nogueira RL; Zangrossi H
Behav Pharmacol; 2005 Nov; 16(7):543-52. PubMed ID: 16170231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
